856898-35-6

Upstream product

• 6942-37-6 5-amino-2-bromo-benzoic acid methyl ester 
• 124-63-0 methanesulfonyl chloride 
• 6942-36-5 methyl 2-bromo-5-nitrobenzoate 

Downstream Products

• 1256489-09-4 C₃₃H₃₆N₂O₇S 
• 1256489-08-3 C₃₃H₃₄N₂O₇S 
• 1256488-89-7 C₃₃H₃₂N₂O₅S 
• 1256488-98-8 C₂₆H₃₂N₂O₆S 
• 1256489-18-5 C₃₃H₃₈N₂O₆S 
• 1256489-10-7 C₂₇H₃₄BNO₇S 
• 1256488-99-9 C₂₈H₃₀N₂O₇S 
• 1256489-11-8 C₂₆H₂₇N₃O₆S 
• 1256488-92-2 C₂₂H₂₄BrNO₅S 
• 1256488-93-3 C₂₁H₂₂BrNO₅S 
• 1256488-87-5 methyl 2-ethynyl-5-(methylsulfonamido)benzoate 
• 1256488-53-5 N-{3-[3-tert-Butyl-5-(2,4-dioxo-1,2,3,4-tetrahydro-pyrimidin-5-yl)-2-methoxy-phenyl]-1-oxo-1H-isochromen-7-yl}-methanesulfonamide 
• 1256488-43-3 N-{3-[3-tert-butyl-2-methoxy-5-(6-methoxy-2-oxo-1,2-dihydro-pyridin-3-yl)-phenyl]-1-oxo-1H-isochromen-7-yl}-methanesulfonamide 
• 1256488-55-7 N-{3-[3-tert-Butyl-2-methoxy-5-(3-oxo-2,3-dihydro-pyridazin-4-yl)-phenyl]-1-oxo-1H-isochromen-7-yl}-methanesulfonamide 

Relevant academic research and scientific papers

HETEROCYCLIC ANTIVIRAL COMPOUNDS

Compounds having the formula I wherein wherein R1, R2, R3b, R4a, R4b, R4c and as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods

Compounds, Compositions and Methods

Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.